reference/2717832

Predicate	Object
contentType	Letter\|Comment
endingPage	1072
issn	2284-0729
issueIdentifier	4
pageRange	1070-1072
publicationName	European review for medical and pharmacological sciences
startingPage	1070
bibliographicCitation	Ramaswamy P, Sibin MK, Misra P, Sahu R. Can the cardioprotective effect of microRNA-103 inhibitors be extended to women with polycystic ovary syndrome? Eur Rev Med Pharmacol Sci. 2022 Feb;26(4):1070–2. doi: 10.26355/eurrev_202202_28094. PMID: 35253160.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_488919f23ce1fc1331ce976fbcaf0379 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8fe6026107a53bcd3b53e9978c77ab2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfa547e6e5296b44e2386ebd4f2f734b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_642c4f87345cc2feb71b23906e0ea839
date	202202
identifier	https://doi.org/10.26355/eurrev_202202_28094 https://pubmed.ncbi.nlm.nih.gov/35253160
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21375 https://portal.issn.org/resource/ISSN/2284-0729
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Can the cardioprotective effect of microRNA-103 inhibitors be extended to women with polycystic ovary syndrome?
discusses	http://id.nlm.nih.gov/mesh/M0407989 http://id.nlm.nih.gov/mesh/M0540712
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011085Q000188 http://id.nlm.nih.gov/mesh/D011085Q000235 http://id.nlm.nih.gov/mesh/D035683Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801

Total number of triples: 27.